345 related articles for article (PubMed ID: 26308769)
61. [Primary diffuse large B-cell lymphoma of testis: a clinicopathologic study of 14 cases].
Li D; Mi C; Zhao Y; Wang YL; Ma Y; Li YY; Xiang MH
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):461-5. PubMed ID: 17845759
[TBL] [Abstract][Full Text] [Related]
62. Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma.
Nagai H; Yano T; Watanabe T; Uike N; Okamura S; Hanada S; Kawano F; Sunami K; Inoue N; Sawamura M; Nishiura T; Hotta T; Horibe K
Br J Haematol; 2008 Dec; 143(5):672-80. PubMed ID: 18950459
[TBL] [Abstract][Full Text] [Related]
63. Early relapse in a case of primary bone marrow diffuse large B-cell lymphoma treated with rituximab-CHOP.
Wang W; Zhou GY; Zhang W
Immunotherapy; 2017 Mar; 9(5):379-385. PubMed ID: 28357915
[TBL] [Abstract][Full Text] [Related]
64. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.
Liu PP; Wang KF; Jin JT; Bi XW; Sun P; Wang Y; Yang H; Li ZM; Jiang WQ; Xia Y
Cancer Med; 2018 May; 7(5):1845-1851. PubMed ID: 29624913
[TBL] [Abstract][Full Text] [Related]
65. Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.
El-Galaly TC; Cheah CY; Hutchings M; Mikhaeel NG; Savage KJ; Sehn LH; Barrington S; Hansen JW; Poulsen MØ; Smith D; Rady K; Mylam KJ; Larsen TS; Holmberg S; Juul MB; Cordua S; Clausen MR; Jensen KB; Bøgsted M; Johnsen HE; Seymour JF; Connors JM; Brown PD; Villa D
Br J Haematol; 2016 Dec; 175(5):876-883. PubMed ID: 27681999
[TBL] [Abstract][Full Text] [Related]
66. Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma.
Koresawa R; Yamazaki K; Oka D; Fujiwara H; Nishimura H; Akiyama T; Hamasaki S; Wada H; Sugihara T; Sadahira Y
Br J Haematol; 2016 Jul; 174(2):264-74. PubMed ID: 27061580
[TBL] [Abstract][Full Text] [Related]
67. Prognostic Significance of LDH Ratio in Serum/Cerebral Spinal Fluid of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma.
Liu YZ; Luo P; Liu C; Xue K; Jin J; Xia ZG; Liu XJ; Zhang QL; Cao JN; Hong XN; Lv FF
Onco Targets Ther; 2019; 12():10469-10475. PubMed ID: 31819527
[TBL] [Abstract][Full Text] [Related]
68. Adaptive B cell responses in rituximab-treated diffuse large B cell lymphoma patients during complete remission.
Cha Z; Li C; Zang Y; Gu H; Guo H; Li J; Fang Y; Petersen TF; Li J; Karas RO; Hamilton ML; Qian B
Tumour Biol; 2016 Jan; 37(1):829-35. PubMed ID: 26254098
[TBL] [Abstract][Full Text] [Related]
69. Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.
Wang S; Wang L; Hu J; Qian W; Zhang X; Hu Y; Zhu Q; Chen B; Wu D; Chang CH; Xu P; Zheng X; Wei J; Liu Y; Cui G; Tang Y; Ma Y; Huang H; Yi H; Zhao W
Cancer Commun (Lond); 2021 Mar; 41(3):229-239. PubMed ID: 33482051
[TBL] [Abstract][Full Text] [Related]
70. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
Ryan G; Martinelli G; Kuper-Hommel M; Tsang R; Pruneri G; Yuen K; Roos D; Lennard A; Devizzi L; Crabb S; Hossfeld D; Pratt G; Dell'Olio M; Choo SP; Bociek RG; Radford J; Lade S; Gianni AM; Zucca E; Cavalli F; Seymour JF;
Ann Oncol; 2008 Feb; 19(2):233-41. PubMed ID: 17932394
[TBL] [Abstract][Full Text] [Related]
71.
Hu B; Nastoupil LJ; Loghavi S; Westin JR; Thakral B; Fayad LE; Hagemeister F; Neelapu S; Samaniego F; Lee HJ; Wang ML; Fanale M; Fowler N; Oki Y
Leuk Lymphoma; 2020 Feb; 61(2):328-336. PubMed ID: 31533521
[TBL] [Abstract][Full Text] [Related]
72. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis.
Haque W; Dabaja B; Tann A; Khan M; Szeja S; Butler EB; Teh BS
Radiother Oncol; 2016 Jul; 120(1):150-5. PubMed ID: 27373911
[TBL] [Abstract][Full Text] [Related]
73. Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome.
Vannata B; Conconi A; Winkler J; Cascione L; Margiotta Casaluci G; Nassi L; Moia R; Pirosa MC; Moccia AA; Stathis A; Rossi D; Gaidano G; Zucca E
Br J Haematol; 2019 Nov; 187(4):478-487. PubMed ID: 31385291
[TBL] [Abstract][Full Text] [Related]
74. Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database.
Liu PP; Xia Y; Bi XW; Wang Y; Sun P; Yang H; Li ZM; Jiang WQ
Dis Markers; 2018; 2018():7473935. PubMed ID: 30410635
[TBL] [Abstract][Full Text] [Related]
75. IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era.
Chen X; Zang Y; Li D; Guo J; Wang Y; Lin Y; Wei Z
Medicine (Baltimore); 2020 May; 99(21):e19883. PubMed ID: 32481253
[TBL] [Abstract][Full Text] [Related]
76. High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.
Zhou Z; Rademaker AW; Gordon LI; LaCasce AS; Crosby-Thompson A; Vanderplas A; Abel GA; Rodriguez MA; Nademanee A; Kaminski MS; Czuczman MS; Millenson MM; Zelenetz AD; Niland J; Friedberg JW; Winter JN
J Natl Compr Canc Netw; 2016 Oct; 14(10):1274-1281. PubMed ID: 27697981
[TBL] [Abstract][Full Text] [Related]
77. Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma.
Ho JC; Dabaja BS; Milgrom SA; Smith GL; Reddy JP; Mazloom A; Young KH; Deng L; Medeiros LJ; Dong W; Allen PK; Andraos TY; Fowler NH; Nastoupil LJ; Oki Y; Fayad LE; Turturro F; Neelapu SS; Westin J; Hagemeister FB; Rodriguez MA; Pinnix CC
Leuk Lymphoma; 2017 Dec; 58(12):2833-2844. PubMed ID: 28482717
[TBL] [Abstract][Full Text] [Related]
78. [Clinical Characteristics and Prognosis of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma].
Zhang XL; Yu WJ; Zhu YN; Xu HL; Yang CM; Xiao F; Mai WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1372-1378. PubMed ID: 37846687
[TBL] [Abstract][Full Text] [Related]
79. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
Tao L; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers CR; Keegan THM
Br J Haematol; 2017 Jul; 178(1):72-80. PubMed ID: 28542862
[TBL] [Abstract][Full Text] [Related]
80. Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
Barrans SL; Fenton JA; Banham A; Owen RG; Jack AS
Blood; 2004 Nov; 104(9):2933-5. PubMed ID: 15238418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
